about
Demyelinating syndrome in SLE encompasses different subtypes: Do we need new classification criteria? Pooled results from systematic literature review and monocentric cohort analysis.Biologics-induced autoimmune renal disorders in chronic inflammatory rheumatic diseases: systematic literature review and analysis of a monocentric cohort.Killer-cell immunoglobulin-like receptors (KIR) and HLA-class I heavy chains in ankylosing spondylitis.New Approaches in Tumor Necrosis Factor Antagonism for the Treatment of Psoriatic Arthritis: Certolizumab Pegol.Predictors of flares in Systemic Lupus Erythematosus: Preventive therapeutic intervention based on serial anti-dsDNA antibodies assessment. Analysis of a monocentric cohort and literature review.Current perspective on the role of the interleukin-23/interleukin-17 axis in inflammation and disease (chronic arthritis and psoriasis).The use of ultrasound to assess giant cell arteritis: review of the current evidence and practical guide for the rheumatologist.Population-based analysis of hospitalizations for patients with systemic sclerosis in a West-European region over the period 2001-2012.Population-based analysis of hospitalizations in a West-European region revealed major changes in hospital utilization for patients with systemic lupus erythematosus over the period 2001-2012.Severe neuropsychiatric systemic lupus erythematosus successfully treated with rituximab: an alternative to standard of care.Failure to achieve lupus low disease activity state (LLDAS) six months after diagnosis is associated with early damage accrual in Caucasian patients with systemic lupus erythematosus.The proposed role of ultrasound in the management of giant cell arteritis in routine clinical practice.Musculoskeletal manifestations as determinants of quality of life impairment in patients with systemic lupus erythematosus.Demyelinating syndrome in SLE: review of different disease subtypes and report of a case series.Protective Effects of Hydroxychloroquine against Accelerated Atherosclerosis in Systemic Lupus Erythematosus.Comment on: Auto-antibodies to double-stranded DNA as biomarker in systemic lupus erythematosus: comparison of different assays during quiescent and active disease.Polymyalgia rheumatica: an autoinflammatory disorder?Expression analysis of HLA-E and NKG2A and NKG2C receptors points at a role for natural killer function in ankylosing spondylitis.Treatment target in newly diagnosed Systemic Lupus ErythematosusAssessment Of Circulating Endothelial Cells And Their Progenitors As Potential Biomarkers Of Disease Activity And Damage Accrual In Behçet's Syndrome
P50
Q31159487-311B6634-9273-47CF-8A8F-E2FDCDDF4A38Q38212745-EE389931-55ED-44AF-8401-B2A7B2386164Q38266317-0A5A544F-816B-41BB-8C56-15C60C3DCFF3Q38622082-2A85B1F6-35E9-46FD-8BD1-DB2EB33A892FQ38752671-2086C876-4CCB-4F44-9A8B-4D940C6289B9Q38912297-028EA1F5-C523-4FDC-8EA7-A2E0B5986786Q39275487-F1535F1C-795F-4007-A441-F3852DFAFC58Q40696023-C74B11AB-22FA-482D-881A-291CF21944FBQ40710206-3A968BF4-A2C7-439F-B2E0-692C6964C217Q42360078-EB433449-2AF3-4789-9E80-F0B846E06378Q44750823-345553B2-67C3-4E92-83EE-8A2E96FA800BQ47605794-CA5880B3-345D-49B1-8A36-4692022896D5Q47692440-E4B090BF-7E50-427B-900B-AE50BB577F6DQ47872183-7140D22A-015A-43E2-9417-F4E2689EA364Q52316454-6E4AC16F-D3E5-4C46-AE77-9130296452D6Q54795653-798F00C2-89A5-42E9-ADC7-54DD8DEB7857Q55378273-C0DAFEAA-3564-4F97-9876-A12B97BC430EQ64981419-013088BA-9B31-475C-BDD3-0DFDACA46E7AQ90627940-2534CAF6-E169-452F-9BD9-BD1E1BE898B4Q90835700-2F2F11FE-40A3-4E11-B488-B42732FE2053
P50
description
researcher ORCID ID = 0000-0002-9154-0576
@en
wetenschapper
@nl
name
Alberto Floris
@ast
Alberto Floris
@en
Alberto Floris
@es
Alberto Floris
@nl
type
label
Alberto Floris
@ast
Alberto Floris
@en
Alberto Floris
@es
Alberto Floris
@nl
prefLabel
Alberto Floris
@ast
Alberto Floris
@en
Alberto Floris
@es
Alberto Floris
@nl
P106
P1153
56173225000
P21
P31
P496
0000-0002-9154-0576